Načítá se...
Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.
We administered 2 g of ceftazidime intravenously every 8 h to cancer patients for the empiric therapy of febrile episodes. Ceftazidime was administered as monotherapy for patients with granulocyte counts in excess of 1,000/microliter. Febrile, neutropenic patients were randomized to also receive eit...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | en |
| Vydáno: |
1985
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180104/ https://ncbi.nlm.nih.gov/pubmed/3890730 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|